Open Access
24.09.2022 | Original Research
Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3
Andrew Blauvelt, Melinda Gooderham, Neal Bhatia, Richard G. Langley, Shannon Schneider, John Zoidis, Azra Kurbasic, April Armstrong, Jonathan I. Silverberg
Open Access
26.09.2022 | Original Research
Patient Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs of Targeted Therapy-Eligible Atopic Dermatitis Patients in Taiwan—A Real-World Study
Chao-Hsiun Tang, Yao-Hsien Huang, Po-Ya Chuang, Bruce C. M. Wang, Ching-Yun Wei, Khai Jing Ng, Tamas Treuer, Chia-Yu Chu
Open Access
28.09.2022 | Brief Report
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study
Cristina Pellegrini, Maria Esposito, Ernesto Rossi, Paolo Gisondi, Stefano Piaserico, Paolo Dapavo, Andrea Conti, Alessio Gambardella, Martina Burlando, Alessandra Narcisi, Annamaria Offidani, Riccardo Balestri, Federico Bardazzi, Francesca Prignano, Cristina Mugheddu, Marco Romanelli, Giovanna Malara, Giovanni Schinzari, Maria Concetta Fargnoli
